Biopol Chemicals IPO
Biopol Chemicals IPO Listing Day Performance
Biopol Chemicals listed on NSE SME on 13 February 2026 at ₹111.00, a 2.78% premium over the issue price of ₹108. A retail investor allotted the minimum application of 2,400 shares (2 lots) gained ₹7,200 at the listing price.
GMP vs actual listing
| Last GMP before listing | ₹1 (+0.9%) |
| GMP-implied listing | ₹109 |
| Actual listing | ₹111.00 |
| Difference | +₹2 (+1.8%) |
Demand going into listing
| Subscribed overall | 22.39× |
| QIB | 21.05× |
| NII | 24.62× |
| Retail | 20.8× |
Market Sentiment
IPO Details
Market Lot Size
IPO Reservation
Financial Analysis
Financial Data
Financial Performance
| Metric | 2024 | 2025 | Dec 2025 |
|---|---|---|---|
| Revenue | 17.43 | 49.15 | 48.97 |
| Expense | 15.72 | 43.35 | 40.89 |
| Profit (PAT) | 2.96 | 4.33 | 6.00 |
| Total Assets | 17.56 | 31.48 | 48.88 |
Peer Comparison
| Company | EPS | P/E | Market Cap (Cr) |
|---|---|---|---|
| Rossari Biotech Limited | 24.63 | 20.93 | 16 |
| Fineotex Chemical Limited | 9.44 | 2.30 | 19 |
| Indian Emulsifiers Limited | 10.88 | 7.19 | 20 |
Promoters & Holding Pattern
Promoters: Mr. Santanu Sarkar And Mr. Vedant Sarkar
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 79,11,000 | 89.88% |
| Promoter Holding Post Issue | 1,08,05,400 | 65.81% |
Strengths & Risks
- Strongly subscribed — 22.4x overall (final).
- Strong institutional (QIB) demand — 21.1x.
- Revenue grew 182% in the latest reported year.
- Solid profit margin — 8.8%.
- Strong return on equity — 38%.
- Lists on the exchange's SME platform, where trading is usually thinner than on the main board — selling at your price can be harder.
From this issue's live data. Not investment advice — read the RHP.
Company Information
Biopol Chemicals at a glance
From the company's description: “Since its incorporation in 2023, Biopal Chemicals has been involved in the manufacturing and distribution of specialty chemicals like silicones, emulsifiers, biochemicals, and polyelectrolytes.”
Biopol Chemicals is raising ₹31.26 crore through an IPO on the NSE Emerge (SME) in the Chemicals sector. All of it is a fresh issue: there is no offer for sale, so every rupee raised goes to the company rather than to selling shareholders. Main stated uses of the fresh money: Acquisition of industrial land (₹12.26 crore) and Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banki… (₹11.1 crore).
Revenue went from ₹17.43 crore in 2024 to ₹49.15 crore in 2025, up 182% over 1 year. Profit after tax went from ₹2.96 crore to ₹4.33 crore, a net margin of 8.8% in the latest year.
The promoter, Mr. Santanu Sarkar And Mr. Vedant Sarkar, holds 90% before the issue and 66% after it — a dilution of 24.1 percentage points. Debt stands at 0.57 times equity.
Written from the issue's offer-document figures shown on this page. Not investment advice.
Company Contact Information
Biopol Chemicals Ltd, D-211, 2nd Floor, Block-D,, Sumel Business Park-6 Near Dudheshwar Circle, Dudheshwar Tavdipura, Ahmedabad, Gujarat, 380004
Objects of the Issue
| Purpose | Amount (Cr) |
|---|---|
| Acquisition of industrial land | 12.26 |
| Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies | 11.10 |
| General Corporate Purpose | - |
Resources & Documents
IPO Documents
Draft Red Herring ProspectusBiopol Chemicals IPO - Quick Take
Biopol Chemicals has set a price band of Rs 104–Rs 108 per share for an issue size of Rs 31 crore in the chemicals sector. The stock listed with a 2.78% gain versus its issue price on February 13, 2026.
The company operates in the chemicals space.
The issue is promoted by Mr. Santanu Sarkar And Mr. Vedant Sarkar with Smart Horizon Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards acquisition of industrial land (Rs 12 crore) and repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and… (Rs 11 crore).
On fundamentals, the company is posting revenue growth of 182.0%, a profit margin of 8.8%, return on equity of 38.1% in its most recent reported period. Listed peers in this segment include Indian Emulsifiers Limited (P/E 7.19x, market cap Rs 20 crore) and Fineotex Chemical Limited (P/E 2.30x, market cap Rs 19 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.
On our data-signal score, the combined signals for this issue currently read mixed — some indicators read positively and others do not. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Biopol Chemicals IPO: Lead Manager & Registrar Track Record
How the firm running this issue and its registrar have fared on the other IPOs we track. Each firm's figures leave out Biopol Chemicals itself, so they describe what came before it.
- Biopol Chemicals listed at +2.8% on day one; the median of 193 listings was +1.5% (better than 56% of them).
- Subscribed 22.39x against a median of 3.98x across 192 issues (higher than 66%).
- Average listing-day move across all 194 SME listings we track: +11.6%.
| Firm | Other IPOs | Listed at / above issue | Avg move | Median |
|---|---|---|---|---|
| Smart Horizon Capital Advisors Pvt. Ltd. Lead manager | 14 3 MB · 11 SME | 93% 13 of 14 | +4.5% | +2% |
| Bigshare Services Pvt.Ltd. Registrar | 61 19 MB · 42 SME | 67% 41 of 61 | Check allotment → | |
Recent listings managed by Smart Horizon Capital Advisors Pvt. Ltd. (5)
Best: Metalic Technoforge +13% · Weakest: PNGS Reva Diamond −2.9%
| IPO | Listed | Listing-day move |
|---|---|---|
| Bombay Coated and Special Steels | 05 Nov 2026 | +12.2% |
| Carver Roboweld | 04 Nov 2026 | +12.5% |
| Wiscon Industries | 03 Nov 2026 | +0% |
| Unitec Fibres | 30 Sep 2026 | +2.3% |
| Infrax Renewable | 17 Sep 2026 | +0% |
A SEBI-registered merchant banker that runs the issue: due diligence, drafting the offer document, setting the price band with the company, and marketing the IPO to investors.
Finalises the basis of allotment, credits shares to demat accounts, releases blocked funds for unsuccessful bids and handles investor queries about the issue.
Listing-day move = exchange opening price vs issue price (band ceiling where the final price isn't recorded). Counts cover IPOs we track only. Past listings don't predict this one; this is not investment advice.
Frequently Asked Questions
Biopol Chemicals IPO GMP — What It Means
Its last GMP before listing was 0.9%. Of the 54 SME IPOs we have tracked with a final GMP under 10%, 21 listed above, 14 flat and 19 below the issue price; Biopol Chemicals listed 2.8% above its issue price.
See the full Biopol Chemicals GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
Same sector or same stage as Biopol ChemicalsNo comments yet. Be the first to share your opinion!